Ex­clu­sive: Cell ther­a­py biotech brings on Loxo vet amid glob­al ex­pan­sion plans; Re­tire­ment beck­ons for Vir's George Scan­gos

Bree Har­lin, who used to be di­rec­tor of clin­i­cal op­er­a­tions at Loxo On­col­o­gy, now Loxo@Lil­ly, is now in the C-suite for the first time.

Har­lin start­ed at TC Bio­Pharm on Wednes­day as chief clin­i­cal of­fi­cer, the biotech an­nounced Fri­day — but her jour­ney starts more than 20 years be­fore then. Af­ter grad­u­at­ing from col­lege, she moved to Boston, work­ing in acad­e­mia at some of the Har­vard teach­ing hos­pi­tals in en­docrinol­o­gy and CNS.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER